Displaying 1 - 12 of 28
Immune-Mediated and Cholestatic Diseases

Should we focus on managing QoL?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Debate the issues

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Event summary

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How do we holistically treat patients with PBC?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on monitoring ALP?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Welcome and a journey back to 1992

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Personal perspectives: What is the most significant advance in the last 10 years?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts
View
Displaying 1 - 12 of 28